Found: 13
Select item for more details and to access through your institution.
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.
- Published in:
- Rheumatology, 2022, v. 61, n. 6, p. 2388, doi. 10.1093/rheumatology/keab758
- By:
- Publication type:
- Article
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
- Published in:
- Rheumatology, 2022, v. 61, n. 5, p. 2063, doi. 10.1093/rheumatology/keab543
- By:
- Publication type:
- Article
Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR).
- Published in:
- Rheumatology, 2020, v. 59, n. 7, p. 1495, doi. 10.1093/rheumatology/kez408
- By:
- Publication type:
- Article
rationale for Janus kinase inhibitors for the treatment of spondyloarthritis.
- Published in:
- Rheumatology, 2019, v. 58, n. 2, p. 197, doi. 10.1093/rheumatology/key070
- By:
- Publication type:
- Article
Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients.
- Published in:
- Rheumatology, 2018, v. 57, n. 8, p. 1390, doi. 10.1093/rheumatology/key104
- By:
- Publication type:
- Article
End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
- Published in:
- Nephrology Dialysis Transplantation, 2009, v. 24, n. 6, p. 1969, doi. 10.1093/ndt/gfp005
- By:
- Publication type:
- Article
The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
- Published in:
- Nephrology Dialysis Transplantation, 2009, v. 24, n. 5, p. 1635
- By:
- Publication type:
- Article
An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 1, p. 53, doi. 10.1007/s40744-022-00498-x
- By:
- Publication type:
- Article
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 2, p. 567, doi. 10.1007/s40744-018-0131-5
- By:
- Publication type:
- Article
Monotherapy rapamycin allows an increase of CD4<sup>+</sup> CD25<sup>bright+</sup> FoxP3<sup>+</sup> T cells in renal recipients.
- Published in:
- Transplant International, 2009, v. 22, n. 9, p. 884, doi. 10.1111/j.1432-2277.2009.00890.x
- By:
- Publication type:
- Article
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1739-0
- By:
- Publication type:
- Article